Masayuki Mori
Department of Community Medicine, Kanazawa Medical University, Uchinada, 920 Ishikawa, Japan
Wentao He
Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China
Yasuhiro Kawasaki
Department of Neuropsychiatry, Kanazawa Medical University, 920-0293 Ishikawa, Japan
Nobuo Kato
Department of Physiology, Kanazawa Medical University, 920-0293 Ishikawa, Japan
Yuji Kasamaki
Department of Community Medicine, Kanazawa Medical University, Uchinada, 920 Ishikawa, Japan
Tsugiyasu Kanda
Department of Community Medicine, Kanazawa Medical University, Uchinada, 920 Ishikawa, Japan
LiveDNA: 81.16286
PDF Fulltext XML References Citation
How to cite this article
Masayuki Mori, Wentao He, Yasuhiro Kawasaki, Nobuo Kato, Yuji Kasamaki and Tsugiyasu Kanda, 2017. Alogliptin, DPP4 Inhibitor, Improved Cognitive and Depressive Function in Obese ApoE-/- Mice with Modification of BDNF in Hippocampus. International Journal of Pharmacology, 13: 1079-1085.
DOI: 10.3923/ijp.2017.1079.1085
URL: https://scialert.net/abstract/?doi=ijp.2017.1079.1085
DOI: 10.3923/ijp.2017.1079.1085
URL: https://scialert.net/abstract/?doi=ijp.2017.1079.1085